Louis Bessette
发表论文 12 篇 · 总被引 291 次 · h-index 4
代表论文
- Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis (2018 · Arthritis & Rheumatology · 被引 301)
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and (2018 · The Lancet · 被引 268)
- Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study. (2018 · Clinical Therapeutics · 被引 19)
- Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study (2018 · Rheumatology and Therapy · 被引 10)
- Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study. (2018 · Clinical Therapeutics · 被引 5)
- Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN) (2026 · Rheumatology and Therapy · 被引 1)